Stonebridge Capital Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Stonebridge Capital Advisors’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-314	Closed	-$2.55K	–	1018
2023 Q1	$2.55K	Hold	314	–	–	﹤0.01%	786
2022 Q4	$3.73K	Hold	314	–	–	﹤0.01%	734
2022 Q3	$4K	Hold	314	–	–	﹤0.01%	723
2022 Q2	$11K	Hold	314	–	–	﹤0.01%	584
2022 Q1	$13K	Hold	314	–	–	﹤0.01%	633
2021 Q4	$13K	Hold	314	–	–	﹤0.01%	602
2021 Q3	$21K	Sell	314 -315	-50%	-$23.1K	﹤0.01%	488
2021 Q2	$45K	Buy	629 +315	+100%	+$19.2K	﹤0.01%	490
2021 Q1	$21K	Hold	314	–	–	﹤0.01%	498
2020 Q4	$11K	Hold	314	–	–	﹤0.01%	189
2020 Q3	$17K	Hold	314	–	–	﹤0.01%	181
2020 Q2	$12K	Hold	314	–	–	﹤0.01%	476
2020 Q1	$8K	Hold	314	–	–	﹤0.01%	513
2019 Q4	$15K	Sell	314 -357	-53%	-$17.3K	﹤0.01%	498
2019 Q3	$33K	Hold	671	–	–	0.01%	381
2019 Q2	$61K	Hold	671	–	–	0.01%	292
2019 Q1	$99K	Hold	671	–	–	0.02%	179
2018 Q4	$106K	Buy	671 +207	+45%	+$39.7K	0.02%	155
2018 Q3	$114K	Hold	464	–	–	0.02%	163
2018 Q2	$104K	Hold	464	–	–	0.02%	163
2018 Q1	$114K	Hold	464	–	–	0.03%	165
2017 Q4	$143K	Hold	464	–	–	0.03%	164
2017 Q3	$170K	Buy	464 +71	+18%	+$25.2K	0.04%	163
2017 Q2	$143K	Buy	393 +72	+22%	+$21.6K	0.04%	150
2017 Q1	$96K	Buy	321 +100	+45%	+$25.2K	0.03%	149
2016 Q4	$49K	Buy	+221	New	+$44.3K	0.01%	147

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Stonebridge Capital Advisors's DMK Position: Q2 2023 in Review

Stonebridge Capital Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 314 shares — an estimated $2.55K sold.

Stonebridge Capital Advisors first reported a position in DMK in Q4 2016 and held it in 26 quarters. The position peaked at $170K in Q3 2017. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

Stonebridge Capital Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 314 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $2.55K.
Stonebridge Capital Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and held it in 26 quarters.
Stonebridge Capital Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $170K in Q3 2017.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2023, filed 23 Aug 2023.